Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine

Margie H Danchin; Carl D Kirkwood; Katherine J Lee; Ruth F Bishop; Emma Watts; Frances A Justice; Vanessa Clifford; Donna Cowley; James Peter Buttery; Julie E Bines

doi:10.1016/j.vaccine.2013.04.008

Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine

Margie H Danchin, Carl D Kirkwood, Katherine J Lee, Ruth F Bishop, Emma Watts, Frances A Justice, Vanessa Clifford, Donna Cowley, James Peter Buttery, Julie E Bines

Paediatrics Monash Health

Research output: Contribution to journal › Article › Research › peer-review

36 Citations (Scopus)

Abstract

RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.

Original language	English
Pages (from-to)	2610 - 2616
Number of pages	7
Journal	Vaccine
Volume	31
Issue number	23
DOIs	https://doi.org/10.1016/j.vaccine.2013.04.008
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.vaccine.2013.04.008

Cite this

@article{1743be66af6b46669c36540571b1d329,

title = "Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine",

abstract = "RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.",

author = "Danchin, {Margie H} and Kirkwood, {Carl D} and Lee, {Katherine J} and Bishop, {Ruth F} and Emma Watts and Justice, {Frances A} and Vanessa Clifford and Donna Cowley and Buttery, {James Peter} and Bines, {Julie E}",

year = "2013",

doi = "10.1016/j.vaccine.2013.04.008",

language = "English",

volume = "31",

pages = "2610 -- 2616",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

number = "23",

}

TY - JOUR

T1 - Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine

AU - Danchin, Margie H

AU - Kirkwood, Carl D

AU - Lee, Katherine J

AU - Bishop, Ruth F

AU - Watts, Emma

AU - Justice, Frances A

AU - Clifford, Vanessa

AU - Cowley, Donna

AU - Buttery, James Peter

AU - Bines, Julie E

PY - 2013

Y1 - 2013

N2 - RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.

AB - RV3 is a human neonatal virus strain (G3P[6]) that has been associated with asymptomatic neonatal infection and replicates well in the infant gut. RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.

UR - http://www.sciencedirect.com/science/article/pii/S0264410X13004271

U2 - 10.1016/j.vaccine.2013.04.008

DO - 10.1016/j.vaccine.2013.04.008

M3 - Article

SN - 0264-410X

VL - 31

SP - 2610

EP - 2616

JO - Vaccine

JF - Vaccine

IS - 23

ER -

Phase I trial of RV3-BB rotavirus vaccine: a human neonatal rotavirus vaccine

Abstract

UN SDGs

Access to Document

Other files and links

Cite this